Skip to content

Straumann® Dental Implant System Roxolid® SLA Impl. SLA Roxolid BL (REF 021.4514)Recalls & reported problems

Institut Straumann AG · Bone Level Implant, D 4.1mm RC, SLA® 14mm, Roxolid®, Loxim™ · Class 2 · Implant

All models of Straumann Dental Implant System Roxolid SLA Impl. (80)

Data updated Oct 18, 2026 from official FDA records · Editorial policy

Quick summary

This Straumann bone level implant has 750 reports, with no deaths and 750 injuries. Most reports describe failure to bond with the bone, and others describe bonds that were lost later. Some patient reports mention pain, infection, or tissue damage. No recalls name this device.

AI-generated from the FDA records on this page and checked automatically against the numbers below. Read the details before relying on it.

Adverse event reports
747
Deaths reported
0
Injuries reported
747
Recalls naming it
0

Summary

The FDA's MAUDE database contains 747 adverse event reports that list this exact device (DI 07630031706973), received between Sep 9, 2019 and Sep 7, 2026 — classified as 747 injuries.

The most frequently reported specific device problem is “Failure to Osseointegrate” (509 reports).

2 other recalls cover devices cleared under the same FDA submission (K150938); they may or may not involve this specific model.

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Reports received per month

Nov 2023: 8 reportsDec 2023: 10 reportsJan 2024: 4 reportsFeb 2024: 13 reportsMar 2024: 10 reportsApr 2024: 5 reportsMay 2024: 11 reportsJun 2024: 8 reportsJul 2024: 5 reportsAug 2024: 10 reportsSep 2024: 11 reportsOct 2024: 16 reportsNov 2024: 9 reportsDec 2024: 16 reportsJan 2025: 6 reportsFeb 2025: 4 reportsMar 2025: 6 reportsApr 2025: 1 reportsMay 2025: 0 reportsJun 2025: 33 reportsJul 2025: 3 reportsAug 2025: 9 reportsSep 2025: 4 reportsOct 2025: 4 reportsNov 2025: 3 reportsDec 2025: 3 reportsJan 2026: 8 reportsFeb 2026: 10 reportsMar 2026: 3 reportsApr 2026: 5 reportsMay 2026: 14 reportsJun 2026: 9 reportsJul 2026: 4 reportsAug 2026: 4 reportsSep 2026: 1 reportsOct 2026: 0 reports20242025202633
Last 36 months. The most recent month may be incomplete.

Most reported problems

Device problems

  • Failure to Osseointegrate509
  • Loss of Osseointegration166
  • Adverse Event Without Identified Device or Use Problem52
  • Difficult to Insert20
  • Fracture2
  • Unintended Movement2
  • Separation Failure1
  • Therapeutic or Diagnostic Output Failure1

Patient problems

  • Fibrosis245
  • No Clinical Signs, Symptoms or Conditions243
  • Pain194
  • Unspecified Infection173
  • Tissue Damage86
  • Inflammation71
  • Swelling/ Edema51
  • Hemorrhage/Blood Loss/Bleeding40

Recent adverse event reports

The 25 most recent of 747 reports, in the reporter's own words as published by the FDA.

  • InjurySep 7, 2026Loss of Osseointegration

    Patient problems: Fistula; Inflammation; Pain

    MAUDE report 50655365 ↗
  • InjuryAug 24, 2026Failure to Osseointegrate

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 50414673 ↗
  • InjuryAug 17, 2026Failure to Osseointegrate

    The clinician reports the implant was inserted 2026 (b)(6) in ADA 11. On 2026 (b)(6), non-osseointegration was verified. Patient presented with bone type III. The device was forwarded to the manufacturer. At the event the patient experienced: Bleeding. No further patient complications were reported.

    Patient problems: Hemorrhage/Blood Loss/Bleeding

    MAUDE report 50282527 ↗
  • InjuryAug 17, 2026Failure to Osseointegrate

    The clinician reports the implant was inserted (b)(6) 2026 in ADA 11. On (b)(6) 2026, non-osseointegration was verified. Patient presented with bone type III. The device was forwarded to the manufacturer. At the event the patient experienced: Bleeding. No further patient complications were reported.

    Patient problems: Hemorrhage/Blood Loss/Bleeding

    MAUDE report 50281014 ↗
  • InjuryAug 3, 2026Failure to Osseointegrate

    Patient problems: Fibrosis; Hyperresponsive to stimuli

    MAUDE report 50119890 ↗
  • InjuryJul 27, 2026Loss of Osseointegration

    The clinician reports the implant was inserted (b)(6) 2018 in FDI 24. On (b)(6) 2026, loss of osseointegration was verified. Patient presented with fair oral hygiene. The device was forwarded to the manufacturer. At the event the patient experienced: Peri-implantitis, Pain, Mobility and Swelling. No further patient complications were reported.

    Patient problems: Fibrosis; Pain; Swelling/ Edema; Unspecified Infection

    MAUDE report 50042673 ↗
  • InjuryJul 27, 2026Failure to Osseointegrate

    The clinician reports the implant was inserted (b)(6) 2026 in the patient's mouth. On (b)(6) 2026, non-osseointegration was verified. The device was forwarded to the manufacturer. There were no reported patient injuries or complications.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 50023549 ↗
  • InjuryJul 3, 2026Failure to Osseointegrate

    THE CLINICIAN REPORTS THE IMPLANT WAS INSERTED (B)(6) 2026 IN FDI 12. DETAILS OF SURGERY: IMPLANT SURFACE NOT COMPLETELY COVERED WITH BONE. ON (B)(6) 2026, NON-OSSEOINTEGRATION WAS VERIFIED. PATIENT PRESENTED WITH BONE TYPE III AND INADEQUATE BONE QUALITY/QUANTITY. THE DEVICE WAS FORWARDED TO THE MANUFACTURER. AT THE EVENT THE PATIENT EXPERIENCED: MOBILITY. NO FURTHER PATIENT COMPLICATIONS WERE REPORTED.

    Patient problems: Fibrosis

    MAUDE report 25706094 ↗
  • InjuryJul 3, 2026Failure to Osseointegrate

    THE CLINICIAN REPORTS THE IMPLANT WAS INSERTED (B)(6) 2026 IN THE PATIENT'S MOUTH. ON (B)(6) 2026, NON-OSSEOINTEGRATION WAS VERIFIED. THE DEVICE WAS FORWARDED TO THE MANUFACTURER. THERE WERE NO REPORTED PATIENT INJURIES OR COMPLICATIONS.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 25705968 ↗
  • InjuryJun 19, 2026Loss of Osseointegration

    THE CLINICIAN REPORTS THE IMPLANT WAS INSERTED (B)(6) 2016 IN FDI 46. DETAILS OF SURGERY: IMPLANT SURFACE NOT COMPLETELY COVERED WITH BONE. ON (B)(6) 2025, LOSS OF OSSEOINTEGRATION WAS VERIFIED. THE DEVICE WAS FORWARDED TO THE MANUFACTURER. AT THE EVENT THE PATIENT EXPERIENCED: PERI-IMPLANTITIS. NO FURTHER PATIENT COMPLICATIONS WERE REPORTED.

    Patient problems: Unspecified Infection

    MAUDE report 25565301 ↗
  • InjuryJun 15, 2026Failure to Osseointegrate

    THE CLINICIAN REPORTS THE IMPLANT WAS INSERTED (B)(6) 2025 IN THE PATIENT'S MOUTH. ON (B)(6) 2025, NON-OSSEOINTEGRATION WAS VERIFIED. PATIENT PRESENTED WITH INADEQUATE BONE QUALITY/QUANTITY. NO PRODUCT WAS RETURNED TO THE MANUFACTURER. THERE WERE NO REPORTED PATIENT INJURIES OR COMPLICATIONS.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 25509441 ↗
  • InjuryJun 15, 2026Loss of Osseointegration

    THE CLINICIAN REPORTS THE IMPLANT WAS INSERTED (B)(6) 2025 IN THE PATIENT'S MOUTH. ON (B)(6) 2026, LOSS OF OSSEOINTEGRATION WAS VERIFIED. THE DEVICE WAS FORWARDED TO THE MANUFACTURER. AT THE EVENT THE PATIENT EXPERIENCED: PERI-IMPLANTITIS. NO FURTHER PATIENT COMPLICATIONS WERE REPORTED.

    Patient problems: Unspecified Infection

    MAUDE report 25508124 ↗
  • InjuryJun 15, 2026Loss of Osseointegration

    THE CLINICIAN REPORTS THE IMPLANT WAS INSERTED (B)(6) 2019 IN FDI 37. DETAILS OF SURGERY: IMMEDIATE EXTRACTION SITE. ON (B)(6) 2026, LOSS OF OSSEOINTEGRATION WAS VERIFIED. THE DEVICE WAS FORWARDED TO THE MANUFACTURER. AT THE EVENT THE PATIENT EXPERIENCED: PAIN AND MOBILITY. NO FURTHER PATIENT COMPLICATIONS WERE REPORTED.

    Patient problems: Fibrosis; Pain

    MAUDE report 25507210 ↗
  • InjuryJun 12, 2026Failure to Osseointegrate

    THE CLINICIAN REPORTS THE IMPLANT WAS INSERTED (B)(6) 2026, IN FDI 36. ON (B)(6) 2026, NON-OSSEOINTEGRATION WAS VERIFIED. THE DEVICE WAS FORWARDED TO THE MANUFACTURER. AT THE EVENT THE PATIENT EXPERIENCED: INFECTION, PAIN, MOBILITY AND ABSCESS. NO FURTHER PATIENT COMPLICATIONS WERE REPORTED.

    Patient problems: Abscess; Fibrosis; Pain; Unspecified Infection

    MAUDE report 25490064 ↗
  • InjuryJun 8, 2026Failure to Osseointegrate

    THE CLINICIAN REPORTS THE IMPLANT WAS INSERTED (B)(6) 2026 IN THE PATIENT'S MOUTH. ON (B)(6) 2026, NON-OSSEOINTEGRATION WAS VERIFIED. PATIENT PRESENTED WITH BONE TYPE III. THE DEVICE WAS FORWARDED TO THE MANUFACTURER. AT THE EVENT THE PATIENT EXPERIENCED: MOBILITY. NO FURTHER PATIENT COMPLICATIONS WERE REPORTED.

    Patient problems: Fibrosis

    MAUDE report 25432394 ↗
  • InjuryJun 5, 2026Failure to Osseointegrate

    THE CLINICIAN REPORTS THE IMPLANT WAS INSERTED (B)(6) 2026 IN ADA 7. DETAILS OF SURGERY: RIDGE AUGMENTATION AND IMMEDIATE EXTRACTION SITE. ON (B)(6) 2026, NON-OSSEOINTEGRATION WAS VERIFIED. PATIENT PRESENTED WITH INADEQUATE BONE QUALITY/QUANTITY. THE DEVICE WAS FORWARDED TO THE MANUFACTURER. AT THE EVENT THE PATIENT EXPERIENCED: INFECTION, MOBILITY AND INFLAMMATION. NO FURTHER PATIENT COMPLICATIONS WERE REPORTED.

    Patient problems: Fibrosis; Inflammation; Unspecified Infection

    MAUDE report 25412542 ↗
  • InjuryJun 5, 2026Failure to Osseointegrate

    THE CLINICIAN REPORTS THE IMPLANT WAS INSERTED (B)(6) 2026 IN ADA 7. DETAILS OF SURGERY: RIDGE AUGMENTATION AND IMMEDIATE EXTRACTION SITE. ON (B)(6) 2026, NON-OSSEOINTEGRATION WAS VERIFIED. PATIENT PRESENTED WITH INADEQUATE BONE QUALITY/QUANTITY. THE DEVICE WAS FORWARDED TO THE MANUFACTURER. AT THE EVENT THE PATIENT EXPERIENCED: INFECTION, MOBILITY AND INFLAMMATION. NO FURTHER PATIENT COMPLICATIONS WERE REPORTED.

    Patient problems: Fibrosis; Inflammation; Unspecified Infection

    MAUDE report 25411934 ↗
  • InjuryJun 3, 2026Failure to Osseointegrate

    THE CLINICIAN REPORTS THE IMPLANT WAS INSERTED (B)(6) 2025 IN THE PATIENT'S MOUTH. ON (B)(6) 2026, NON-OSSEOINTEGRATION WAS VERIFIED. THE DEVICE WAS FORWARDED TO THE MANUFACTURER. THERE WERE NO REPORTED PATIENT INJURIES OR COMPLICATIONS.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 25379364 ↗
  • InjuryMay 28, 2026Failure to Osseointegrate

    THE CLINICIAN REPORTS THE IMPLANT WAS INSERTED (B)(6) 2025 IN THE PATIENT'S MOUTH. DETAILS OF SURGERY: IMPLANT SURFACE NOT COMPLETELY COVERED WITH BONE. ON (B)(6) 2026, NON-OSSEOINTEGRATION WAS VERIFIED. THE DEVICE WAS FORWARDED TO THE MANUFACTURER. THERE WERE NO REPORTED PATIENT INJURIES OR COMPLICATIONS.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 25320922 ↗
  • InjuryMay 26, 2026Failure to Osseointegrate

    THE CLINICIAN REPORTS THE IMPLANT WAS INSERTED (B)(6) 2025 IN ADA 28. ON (B)(6) 2025, NON-OSSEOINTEGRATION WAS VERIFIED. THE DEVICE WAS FORWARDED TO THE MANUFACTURER. AT THE EVENT THE PATIENT EXPERIENCED: PERI-IMPLANTITIS, PAIN AND MOBILITY. NO FURTHER PATIENT COMPLICATIONS WERE REPORTED.

    Patient problems: Fibrosis; Pain; Unspecified Infection

    MAUDE report 25282724 ↗
  • InjuryMay 26, 2026Failure to Osseointegrate

    THE CLINICIAN REPORTS THE IMPLANT WAS INSERTED (B)(6) 2025 IN FDI 22. ON (B)(6) 2026, NON-OSSEOINTEGRATION WAS VERIFIED. THE DEVICE WAS FORWARDED TO THE MANUFACTURER. AT THE EVENT THE PATIENT EXPERIENCED: PAIN AND MOBILITY. NO FURTHER PATIENT COMPLICATIONS WERE REPORTED.

    Patient problems: Fibrosis; Pain

    MAUDE report 25282359 ↗
  • InjuryMay 26, 2026Failure to Osseointegrate

    THE CLINICIAN REPORTS THE IMPLANT WAS INSERTED (B)(6) 2025 IN FDI 12. ON (B)(6) 2026, NON-OSSEOINTEGRATION WAS VERIFIED. THE DEVICE WAS FORWARDED TO THE MANUFACTURER. AT THE EVENT THE PATIENT EXPERIENCED: PAIN AND MOBILITY. NO FURTHER PATIENT COMPLICATIONS WERE REPORTED.

    Patient problems: Fibrosis; Pain

    MAUDE report 25282323 ↗
  • InjuryMay 26, 2026Failure to Osseointegrate

    THE CLINICIAN REPORTS THE IMPLANT WAS INSERTED (B)(6) 2025 IN ADA 28. ON (B)(6) 2025, NON-OSSEOINTEGRATION WAS VERIFIED. THE DEVICE WAS FORWARDED TO THE MANUFACTURER. AT THE EVENT THE PATIENT EXPERIENCED: PERI-IMPLANTITIS, PAIN AND MOBILITY. NO FURTHER PATIENT COMPLICATIONS WERE REPORTED.

    Patient problems: Fibrosis; Pain; Unspecified Infection

    MAUDE report 25281478 ↗
  • InjuryMay 22, 2026Loss of Osseointegration

    THE CLINICIAN REPORTS THE IMPLANT WAS INSERTED (B)(6) 2022 IN THE PATIENT'S MOUTH. ON (B)(6) 2026, LOSS OF OSSEOINTEGRATION WAS VERIFIED. THE DEVICE WAS FORWARDED TO THE MANUFACTURER. THERE WERE NO PATIENT OPERATIVE OR POST-OPERATIVE COMPLICATIONS REPORTED.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 25259283 ↗
  • InjuryMay 18, 2026Loss of Osseointegration

    THE CLINICIAN REPORTS THE IMPLANT WAS INSERTED (B)(6) 2025 IN FDI 34. ON (B)(6) 2026, LOSS OF OSSEOINTEGRATION WAS VERIFIED. THE DEVICE WAS FORWARDED TO THE MANUFACTURER. AT THE EVENT THE PATIENT EXPERIENCED: MOBILITY. NO FURTHER PATIENT COMPLICATIONS WERE REPORTED.

    Patient problems: Fibrosis

    MAUDE report 25205548 ↗

Recalls under the same FDA submission

These recalls involve devices cleared under K150938. One submission often covers many models, so check the product and lot details in each record.

  • Z-2535-2016 · Jul 14, 2016 · Terminated
    Straumann Bone Level Implant, 4.1mm RC, SLA 12mm, TiZr, NTP Article Number: 021.4512
  • Z-2534-2016 · Jul 14, 2016 · Terminated
    Straumann Bone Level Implant, 4.1mm RC, SLA 10mm, TiZr, NTP Article Number: 021.4510

Other IMPLANT, ENDOSSEOUS, ROOT-FORM devices

All IMPLANT, ENDOSSEOUS, ROOT-FORM devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page